|Bid||0.1100 x 50000|
|Ask||0.1390 x 48000|
|Day's Range||0.1110 - 0.1130|
|52 Week Range||0.1060 - 0.6900|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (CSE: SPR) (FRA: 38G) (OTCQB: SRUTF) ("Sproutly" or the "Company") today announced the Company’s financial results for the third quarter ended November 30, 2019.
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") is pleased to announce it has secured a private loan (the "Loan") of $1 million from Infusion Biosciences Inc., a related party of the Company (the "Lender"). The Loan carries an interest rate of 10% per annum accruing and compounding monthly, payable on maturity on or before October 24, 2020 (the "Maturity Date"). The Company anticipates using the proceeds of the Loan to support the Company’s general working capital.
NEW YORK, Sept. 12, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Sproutly Canada Inc. (SRUTF) (CSE:SPR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. As the legal boundaries of the North American cannabis industry expand, businesses are looking for ways to make the most of their products and reach the widest possible market. Instead, companies are increasingly focused on alternatives such as edible cannabis products.
Sproutly Canada, Inc. (SPR.CN) (38G.F) (SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the year ended February 28, 2019. After going public in July of 2018, we acquired Infusion Biosciences Canada and SSM partners, providing us with access to their ground-breaking APP technology to produce water-soluble cannabinoids (“Infuz2O”) and oil-based cannabinoids (“Bio Natural Oil”) which provides the Company with a differentiating proprietary technology to compete in the infused beverage and edible category. In 2019 we also completed our GTA production facility, received our cultivation license from Health Canada and began full-scale production of all 13 grow rooms” said Keith Dolo, Chief Executive Officer of Sproutly.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that it has successfully completed the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc. at its wholly-owned Toronto Herbal Remedies Inc. (“THR”) licensed facility. This initial APP run successfully recovered both water-soluble cannabinoids (“Infuz2O”), with onset of effects within approximately 5 minutes and which dissipate within approximately 90 minutes, and oil-based cannabinoids (“Bio Natural Oil”), a strain specific cannabis oil. The initial Infuz2O and Bio Natural Oil recovered is expected to be used for R&D and product formulation purposes for cannabis beverages and edibles within the proposed regulations recently announced by Health Canada.
“Recognizing our first commercial sale to another, well recognized, licensed producer is a milestone that we are very proud of. This shipment marks the beginning of Sproutly’s revenue stream and demonstrates our teams ability to, once again, deliver on our strategy.” - said Keith Dolo, Chief Executive Officer, Sproutly Canada. “As Sproutly awaits our Health Canada inspection to achieve our sales license, we may consider selling more wholesale, high quality craft flower, to ensure a consistent inflow of revenue over the coming months.” – states Dolo. Following the receipt of its sales license from Health Canada, Sproutly plans to sell THR’s premium cannabis flower under the CALIBER brand. CALIBER is designed for the cannabis connoisseur and delivered via Sproutly’s craft cannabis flower production. With high-quality manufacturing process, award-winning genetics and distinct premium packaging, the CALIBER brand is expected to deliver a superior cannabis experience for the cannabis connoisseur.
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly” or the “Company”) is pleased to announce it has completed a voluntary debt for shares settlement agreement with an arm’s length creditor (the “Creditor”) whereby the company has settled outstanding current debt in the amount of $3,537,455 (the “Debt”). In settlement of the Debt, the Company has issued 4,716,606 common shares in the capital of the Company (the “Settlement Shares”) at a price of $0.75 per Settlement Share. The Debt was completely extinguished upon the issuance of the Settlement Shares. The Creditor voluntarily elected to satisfy the Debt with common shares in lieu of cash payment.
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that through its wholly owned subsidiary Toronto Herbal Remedies Inc (“THR”), has submitted an amendment for a sales license for cannabis flower. THR has successfully completed its first packaging run for cannabis flower product and has provided all supporting documents to Health Canada. Following a “compliant” rating after their last inspection earlier this year, THR is now looking forward to their next visit from Health Canada in anticipation of receipt of their sales license.
Chief Executive Officer (“CEO”), Keith Dolo, will present at the Canaccord Genuity 3rd annual cannabis conference on May 14th at the Grand Hyatt in New York. CEO Keith Dolo will present as the Cannastocks2019 Q1 investor conference on May 15th, also in New York. Chief Science Officer (“CSO”), Arup Sen, will present at the Cannabis Drinks Expo at the South San Francisco Conference Center in San Francisco on July 25th.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), will be hosting a conference call with Keith Dolo, CEO of Sproutly, Dr. Arup Sen, Chief Science Officer of Sproutly, and Matthew Oland, Moosehead Breweries Limited executive and incoming CEO of the Joint Venture (defined below), at 9:30am Eastern Time on May 1st, 2019. The purpose of the call will be to discuss the recently announced definitive agreement with OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), to form an exclusive joint venture (the “Joint Venture”). A presentation related to the Joint Venture is available on Sproutly’s website www.sproutly.ca as well as at the download link below.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), are pleased to announce that they have entered into a definitive agreement (the “Joint Venture Agreement”) to form an exclusive joint venture (the “Joint Venture” or the “JV”) to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using Sproutly’s proprietary, naturally produced water soluble cannabinoids known as ‘Infuz2O’. Both companies will bring their respective strengths to the joint venture to develop a line of great tasting cannabis beverages featuring a rapid onset and offset effect unique to the category.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), is pleased to announce that the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”), a licensed producer under the Cannabis Act, has received a processing licence from Health Canada effective March 29, 2019 (the “Processing License”). The Processing License allows THR to produce cannabis oil and related products, and will also allow the Company to conduct certain research and development activities, including the formulation of proprietary beverage products. “We are making steady progress towards achieving Sproutly’s mission of delivering a safe and consistent whole plant experience from cannabis, with a lead position in the beverage market.